Korean Gene, Cell Therapies Edge Ahead In Challenging Environment

Despite the challenges in the sector, South Korean biotech companies are making substantial progress in the gene and cell therapy space, with several companies set to begin or already in late stage clinical trials at home and abroad, stepping gradually towards commercialization.

SEOUL - The stem cell and gene therapy market is forecast to grow rapidly with large pharma firms beginning to pay strong attention to the sector, although the industry still needs to overcome challenges such as tough regulations, high prices of therapies, lack of target patients and worries over safety and efficacy of the drugs.

The era of third generation biomedicines including gene and cell therapies appears to have started, with R&D activities in this...